Novartis AG (NOVNN)
BMV
Closed
Aug 21, 2026
Day's Range
2,602.2152 wk Range
2,256.61Overview - NOVNN - Novartis AG
Key Statistics
Valuation
Enterprise Value
84.27T
P/E (Trailing)
‪23.20‬
PEG Ratio
‪-1.33‬
Price / Sales (TTM)
‪87.24‬
Price / Book
‪6.99‬
EV / EBITDA
‪215.94‬
Profitability
Gross Margin
‪75.18%‬
Profit Margin
‪22.50%‬
Operating Margin
‪34.62%‬
Return on Assets
‪10.25%‬
Return on Equity
‪30.35%‬
Ownership
Shares Outstanding
1.90B
Float
1.85B
Held by Insiders
‪2.11%‬
Held by Institutions
‪45.89%‬
Price stats
Beta
‪0.49‬
50-Day Avg
‪2,570.47‬
200-Day Avg
‪2,564.18‬
Dividends
Payout Ratio
‪69.86%‬
Frequency
Annual
Market Cap - NOVNN - Novartis AG
Peers - NOVNN - Novartis AG
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on BMV.
- NOVNNBMVNovartis AG4.94TMarket Cap+13.16%52-week change23.09P/E (Trailing)‪22.50%‬Profit Margin
- JNJBMVJohnson & Johnson11.05TMarket Cap+27.38%52-week change31.45P/E (Trailing)‪21.48%‬Profit Margin
- ABBVBMVAbbVie Inc.7.94TMarket Cap+13.73%52-week change75.19P/E (Trailing)‪9.80%‬Profit Margin
- MRKBMVMerck & Co., Inc.6.36TMarket Cap+36.51%52-week change108.64P/E (Trailing)‪4.76%‬Profit Margin
- ROP1NBMVRoche Holding AG6.26TMarket Cap+4.75%52-week change25.02P/E (Trailing)‪19.60%‬Profit Margin
- NVNVSNBMVNovartis AG Sponsored ADR5.08TMarket Cap+17.59%52-week change23.70P/E (Trailing)‪22.50%‬Profit Margin
- AZN1NBMVAstraZeneca PLC4.21TMarket Cap-9.68%52-week change23.87P/E (Trailing)‪17.02%‬Profit Margin
Profile Summary - NOVNN - Novartis AG
About
Novartis AG is a Swiss multinational pharmaceutical company headquartered in Basel, specializing in innovative medicines across multiple therapeutic areas including cardiovascular, immunology, neuroscience, oncology, and renal and metabolic diseases. The company operates through two primary divisions: Innovative…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
